Related Experiment Video
Updated: Jun 29, 2026
08:42
Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
Takotsubo cardiomyopathy associated with anesthesia: three case reports
F Craig Littlejohn1, Omar Syed, Eugene Ornstein
1Department of Anesthesiology, Columbia University Medical Center, New York, NY, USA. ejh3@columbia.edu.
Cases Journal
|October 10, 2008
Summary
Takotsubo cardiomyopathy, a temporary heart condition, can mimic heart attacks but has a good prognosis. This report details three cases involving anesthesia, highlighting varied causes and management strategies.
Area of Science:
- Cardiology
- Anesthesiology
Background:
- Takotsubo cardiomyopathy is a transient left ventricular dysfunction.
- It often mimics acute coronary events but features normal coronary arteries.
- Postmenopausal women experiencing distress are commonly affected, with a favorable prognosis.
Purpose of the Study:
- To present three cases of Takotsubo cardiomyopathy in patients undergoing procedures involving anesthesia.
- To illustrate different etiologies, patient profiles, procedures, and anesthetic management in Takotsubo cardiomyopathy.
Main Methods:
- Case report series.
- Review of patient history, procedures, and anesthetic management.
- Analysis of clinical presentation and outcomes.
Main Results:
- Three distinct cases of Takotsubo cardiomyopathy associated with anesthesia were identified.
- Each case presented unique triggers and required tailored anesthetic approaches.
- The syndrome's reversibility and generally good prognosis were observed.
Conclusions:
- Takotsubo cardiomyopathy can occur in the context of anesthesia.
- Anesthetic management should consider potential triggers and patient-specific factors.
- Further research into the relationship between anesthesia and Takotsubo cardiomyopathy is warranted.
Related Concept Videos
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
01:17Pericarditis III: Medical Management
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:14Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
01:25Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...